View ValuationNipro 향후 성장Future 기준 점검 1/6Nipro (는) 각각 연간 11.3% 및 3.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 13.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 8.3% 로 예상됩니다.핵심 정보11.3%이익 성장률13.65%EPS 성장률Medical Equipment 이익 성장13.5%매출 성장률3.6%향후 자기자본이익률8.31%애널리스트 커버리지Low마지막 업데이트25 May 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 12Nipro Corporation, Annual General Meeting, Jun 26, 2026Nipro Corporation, Annual General Meeting, Jun 26, 2026.공시 • Mar 09Nipro Corporation to Report Fiscal Year 2026 Final Results on May 12, 2026Nipro Corporation announced that they will report fiscal year 2026 final results on May 12, 2026공시 • Dec 17Nipro Corporation to Report Q3, 2026 Results on Feb 09, 2026Nipro Corporation announced that they will report Q3, 2026 results on Feb 09, 2026공시 • Sep 30Nipro Corporation to Report Q2, 2026 Results on Nov 10, 2025Nipro Corporation announced that they will report Q2, 2026 results on Nov 10, 2025공시 • Jun 03Nipro Corporation to Report Q1, 2026 Results on Aug 08, 2025Nipro Corporation announced that they will report Q1, 2026 results on Aug 08, 2025공시 • May 12+ 3 more updatesNipro Corporation, Annual General Meeting, Jun 26, 2025Nipro Corporation, Annual General Meeting, Jun 26, 2025.공시 • Mar 04Nipro Corporation to Report Fiscal Year 2025 Results on May 12, 2025Nipro Corporation announced that they will report fiscal year 2025 results at 12:00 PM, Tokyo Standard Time on May 12, 2025공시 • Dec 03Nipro Corporation to Report Q3, 2025 Results on Feb 07, 2025Nipro Corporation announced that they will report Q3, 2025 results on Feb 07, 2025Reported Earnings • Nov 10Second quarter 2025 earnings released: JP¥15.31 loss per share (vs JP¥35.76 profit in 2Q 2024)Second quarter 2025 results: JP¥15.31 loss per share (down from JP¥35.76 profit in 2Q 2024). Revenue: JP¥159.6b (up 9.9% from 2Q 2024). Net loss: JP¥2.50b (down 143% from profit in 2Q 2024). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Sep 20Upcoming dividend of JP¥12.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 42% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of German dividend payers (4.8%). Higher than average of industry peers (1.9%).공시 • Aug 29Nipro Corporation to Report Q2, 2025 Results on Nov 08, 2024Nipro Corporation announced that they will report Q2, 2025 results on Nov 08, 2024Buy Or Sell Opportunity • Aug 06Now 22% overvaluedOver the last 90 days, the stock has fallen 2.7% to €7.15. The fair value is estimated to be €5.88, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.8% over the last 3 years. Earnings per share has declined by 25%. For the next 3 years, revenue is forecast to grow by 3.8% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.Declared Dividend • Jul 11Final dividend of JP¥12.00 announcedShareholders will receive a dividend of JP¥12.00. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 168%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (29% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 2.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 36% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Jun 02Nipro Corporation to Report Q1, 2025 Results on Aug 08, 2024Nipro Corporation announced that they will report Q1, 2025 results on Aug 08, 2024Reported Earnings • May 13Full year 2024 earnings released: EPS: JP¥68.11 (vs JP¥28.05 in FY 2023)Full year 2024 results: EPS: JP¥68.11 (up from JP¥28.05 in FY 2023). Revenue: JP¥586.8b (up 7.6% from FY 2023). Net income: JP¥11.1b (up 143% from FY 2023). Profit margin: 1.9% (up from 0.8% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.공시 • May 12Nipro Corporation, Annual General Meeting, Jun 26, 2024Nipro Corporation, Annual General Meeting, Jun 26, 2024.Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.1%. Lower than top quartile of German dividend payers (5.0%). Higher than average of industry peers (1.6%).공시 • Mar 01Nipro Corporation to Report Fiscal Year 2024 Results on May 10, 2024Nipro Corporation announced that they will report fiscal year 2024 results on May 10, 2024Reported Earnings • Feb 11Third quarter 2024 earnings released: EPS: JP¥16.54 (vs JP¥4.35 in 3Q 2023)Third quarter 2024 results: EPS: JP¥16.54 (up from JP¥4.35 in 3Q 2023). Revenue: JP¥153.3b (up 5.0% from 3Q 2023). Net income: JP¥2.70b (up 280% from 3Q 2023). Profit margin: 1.8% (up from 0.5% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.공시 • Nov 29Nipro Corporation to Report Q3, 2024 Results on Feb 08, 2024Nipro Corporation announced that they will report Q3, 2024 results on Feb 08, 2024Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: JP¥35.76 (vs JP¥5.99 in 2Q 2023)Second quarter 2024 results: EPS: JP¥35.76 (up from JP¥5.99 in 2Q 2023). Revenue: JP¥145.3b (up 9.7% from 2Q 2023). Net income: JP¥5.83b (up 497% from 2Q 2023). Profit margin: 4.0% (up from 0.7% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.Upcoming Dividend • Sep 21Upcoming dividend of JP¥10.00 per share at 2.0% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 05 December 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.8%). In line with average of industry peers (2.0%).공시 • Aug 27Nipro Corporation to Report Q2, 2024 Results on Nov 09, 2023Nipro Corporation announced that they will report Q2, 2024 results on Nov 09, 2023New Risk • Aug 10New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 106% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.2% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.8% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 106% Paying a dividend despite having no free cash flows. Minor Risk Profit margins are more than 30% lower than last year (0.6% net profit margin).Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: JP¥25.13 (vs JP¥32.34 in 1Q 2023)First quarter 2024 results: EPS: JP¥25.13 (down from JP¥32.34 in 1Q 2023). Revenue: JP¥140.6b (up 9.9% from 1Q 2023). Net income: JP¥4.10b (down 22% from 1Q 2023). Profit margin: 2.9% (down from 4.1% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.공시 • May 28Nipro Corporation to Report Q1, 2024 Results on Aug 09, 2023Nipro Corporation announced that they will report Q1, 2024 results on Aug 09, 2023Reported Earnings • May 14Full year 2023 earnings released: EPS: JP¥28.05 (vs JP¥82.50 in FY 2022)Full year 2023 results: EPS: JP¥28.05 (down from JP¥82.50 in FY 2022). Revenue: JP¥545.2b (up 10% from FY 2022). Net income: JP¥4.57b (down 66% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Medical Equipment industry in Germany.공시 • May 13Nipro Corporation, Annual General Meeting, Jun 28, 2023Nipro Corporation, Annual General Meeting, Jun 28, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥8.50 per share at 2.2% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (1.7%).Reported Earnings • Feb 09Third quarter 2023 earnings released: EPS: JP¥4.35 (vs JP¥22.90 in 3Q 2022)Third quarter 2023 results: EPS: JP¥4.35 (down from JP¥22.90 in 3Q 2022). Revenue: JP¥146.0b (up 15% from 3Q 2022). Net income: JP¥710.0m (down 81% from 3Q 2022). Profit margin: 0.5% (down from 2.9% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Germany.공시 • Dec 01Nipro Corporation to Report Q3, 2023 Results on Feb 08, 2023Nipro Corporation announced that they will report Q3, 2023 results on Feb 08, 2023Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: JP¥5.99 (vs JP¥24.54 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.99 (down from JP¥24.54 in 2Q 2022). Revenue: JP¥132.4b (up 6.7% from 2Q 2022). Net income: JP¥977.0m (down 76% from 2Q 2022). Profit margin: 0.7% (down from 3.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Germany.Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: JP¥5.99 (vs JP¥24.54 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.99 (down from JP¥24.54 in 2Q 2022). Revenue: JP¥132.4b (up 6.7% from 2Q 2022). Net income: JP¥977.0m (down 76% from 2Q 2022). Profit margin: 0.7% (down from 3.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Medical Equipment industry in Germany.Upcoming Dividend • Sep 22Upcoming dividend of JP¥13.50 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 06 December 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of German dividend payers (5.1%). Higher than average of industry peers (1.8%).공시 • Aug 28Nipro Corporation to Report Q2, 2023 Results on Nov 09, 2022Nipro Corporation announced that they will report Q2, 2023 results on Nov 09, 2022Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: JP¥32.34 (vs JP¥20.23 in 1Q 2022)First quarter 2023 results: EPS: JP¥32.34 (up from JP¥20.23 in 1Q 2022). Revenue: JP¥127.9b (up 8.4% from 1Q 2022). Net income: JP¥5.28b (up 60% from 1Q 2022). Profit margin: 4.1% (up from 2.8% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.3%, compared to a 7.4% growth forecast for the industry in Germany.Reported Earnings • May 13Full year 2022 earnings released: EPS: JP¥82.50 (vs JP¥87.12 in FY 2021)Full year 2022 results: EPS: JP¥82.50 (down from JP¥87.12 in FY 2021). Revenue: JP¥494.8b (up 8.6% from FY 2021). Net income: JP¥13.5b (down 5.3% from FY 2021). Profit margin: 2.7% (down from 3.1% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.7%, compared to a 7.2% growth forecast for the industry in Germany.공시 • May 13Nipro Corporation, Annual General Meeting, Jun 28, 2022Nipro Corporation, Annual General Meeting, Jun 28, 2022.공시 • Apr 08Nipro Corporation to Report Fiscal Year 2022 Results on May 11, 2022Nipro Corporation announced that they will report fiscal year 2022 results on May 11, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.50 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (3.6%). Higher than average of industry peers (1.1%).Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥22.90 (down from JP¥30.07 in 3Q 2021). Revenue: JP¥127.2b (up 7.1% from 3Q 2021). Net income: JP¥3.74b (down 24% from 3Q 2021). Profit margin: 2.9% (down from 4.1% in 3Q 2021). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 4.8%, compared to a 12% growth forecast for the industry in Germany.Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥24.54 (vs JP¥14.99 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥124.1b (up 9.5% from 2Q 2021). Net income: JP¥4.00b (up 64% from 2Q 2021). Profit margin: 3.2% (up from 2.2% in 2Q 2021).Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.50 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 07 December 2021. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (3.2%). Higher than average of industry peers (0.8%).공시 • Sep 09Nipro Corporation's Ordinary Shares to Be Deleted from Other OTCNipro Corporation's Ordinary Shares will be deleted from other OTC effective from September 8, 2021 due to Inactive Security.Reported Earnings • Aug 12First quarter 2022 earnings released: EPS JP¥20.23 (vs JP¥18.57 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: JP¥118.0b (up 8.3% from 1Q 2021). Net income: JP¥3.30b (up 8.9% from 1Q 2021). Profit margin: 2.8% (in line with 1Q 2021).Reported Earnings • May 14Full year 2021 earnings released: EPS JP¥87.12 (vs JP¥75.30 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥455.6b (up 2.9% from FY 2020). Net income: JP¥14.2b (up JP¥26.5b from FY 2020). Profit margin: 3.1% (up from net loss in FY 2020).공시 • Mar 06Nipro Corporation to Report Fiscal Year 2021 Results on May 11, 2021Nipro Corporation announced that they will report fiscal year 2021 results on May 11, 2021Is New 90 Day High Low • Feb 18New 90-day high: €10.90The company is up 18% from its price of €9.25 on 19 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Medical Equipment industry, which is up 28% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.22 per share.Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS JP¥30.07 (vs JP¥30.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: JP¥118.8b (up 4.2% from 3Q 2020). Net income: JP¥4.90b (down 1.4% from 3Q 2020). Profit margin: 4.1% (down from 4.4% in 3Q 2020).Analyst Estimate Surprise Post Earnings • Feb 10Revenue misses expectationsRevenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 7.6%, compared to a 14% growth forecast for the Medical Equipment industry in Germany.공시 • Dec 03Nipro Corporation to Report Q3, 2021 Results on Feb 08, 2021Nipro Corporation announced that they will report Q3, 2021 results on Feb 08, 2021Reported Earnings • Nov 17Second quarter 2021 earnings released: EPS JP¥14.99The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: JP¥113.3b (flat on 2Q 2020). Net income: JP¥2.44b (down 21% from 2Q 2020). Profit margin: 2.2% (down from 2.7% in 2Q 2020). The decrease in margin was driven by higher expenses.Analyst Estimate Surprise Post Earnings • Nov 17Revenue misses expectationsRevenue missed analyst estimates by 5.6%. Over the next year, revenue is forecast to grow 7.2%, compared to a 13% growth forecast for the Medical Equipment industry in Germany.Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS JP¥14.99The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: JP¥113.3b (flat on 2Q 2020). Net income: JP¥2.44b (down 21% from 2Q 2020). Profit margin: 2.2% (down from 2.7% in 2Q 2020). The decrease in margin was driven by higher expenses.Is New 90 Day High Low • Nov 11New 90-day high: €11.50The company is up 21% from its price of €9.50 on 13 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.26 per share.Is New 90 Day High Low • Oct 27New 90-day low: €8.85The company is down 7.0% from its price of €9.50 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.45 per share.공시 • Aug 23Nipro Corporation to Report Q2, 2021 Results on Nov 09, 2020Nipro Corporation announced that they will report Q2, 2021 results on Nov 09, 2020이익 및 매출 성장 예측DB:5FA - 애널리스트 향후 추정치 및 과거 재무 데이터 (JPY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수3/31/2029751,82018,33920,37681,25233/31/2028731,47818,61411,42169,94253/31/2027694,61512,5898,98060,26043/31/2026660,53813,504-7,63454,657N/A12/31/2025652,60915,203N/AN/AN/A9/30/2025649,95110,88917,46370,302N/A6/30/2025651,4145,758N/AN/AN/A3/31/2025644,5865,113-8,13368,461N/A12/31/2024626,9325,074N/AN/AN/A9/30/2024612,9371,307-30,86969,240N/A6/30/2024598,5839,636N/AN/AN/A3/31/2024586,78511,109-21,26772,936N/A12/31/2023578,03310,241N/AN/AN/A9/30/2023570,7258,253-49,13825,407N/A6/30/2023557,9013,398N/AN/AN/A3/31/2023545,1994,574-74,44010,395N/A12/31/2022531,7349,379N/AN/AN/A9/30/2022513,00812,404-34,24046,398N/A6/30/2022504,68015,430N/AN/AN/A3/31/2022494,78913,455-11,58968,214N/A12/31/2021483,83114,870N/AN/AN/A9/30/2021475,42516,039-8,86168,386N/A6/30/2021464,63514,480N/AN/AN/A3/31/2021455,55914,20914,91166,093N/A12/31/2020446,879-12,762N/AN/AN/A9/30/2020442,102-12,694-6,35045,200N/A6/30/2020441,680-12,044N/AN/AN/A3/31/2020442,516-12,281-20,69737,246N/A12/31/2019441,80813,142N/AN/AN/A9/30/2019440,74210,407N/A36,984N/A6/30/2019432,95910,246N/AN/AN/A3/31/2019426,39912,136N/A41,362N/A12/31/2018422,8407,857N/AN/AN/A9/30/2018415,81911,162N/A39,660N/A6/30/2018405,04612,269N/AN/AN/A3/31/2018395,39711,829N/A41,046N/A12/31/2017383,38111,099N/AN/AN/A9/30/2017370,02116,705N/A38,635N/A6/30/2017364,12715,375N/AN/AN/A3/31/2017359,69911,346N/A33,472N/A12/31/2016362,77619,821N/AN/AN/A9/30/2016364,70116,995N/A36,509N/A6/30/2016367,67716,027N/AN/AN/A3/31/2016366,65019,718N/A29,934N/A12/31/2015359,04411,918N/AN/AN/A9/30/2015350,11312,646N/A34,812N/A6/30/2015337,75715,122N/AN/AN/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 5FA 의 연간 예상 수익 증가율(11.3%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: 5FA 의 연간 수익(11.3%)이 German 시장(17.2%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 5FA 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 5FA 의 수익(연간 3.6%)이 German 시장(연간 6.8%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 5FA 의 수익(연간 3.6%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 5FA의 자본 수익률은 3년 후 8.3%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YHealthcare 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/25 14:26종가2026/05/25 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nipro Corporation는 13명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Masahiro NakanomyoBarclaysYuki YamazakiDaiwa Securities Co. Ltd.Stephen BarkerJefferies LLC10명의 분석가 더 보기
공시 • May 12Nipro Corporation, Annual General Meeting, Jun 26, 2026Nipro Corporation, Annual General Meeting, Jun 26, 2026.
공시 • Mar 09Nipro Corporation to Report Fiscal Year 2026 Final Results on May 12, 2026Nipro Corporation announced that they will report fiscal year 2026 final results on May 12, 2026
공시 • Dec 17Nipro Corporation to Report Q3, 2026 Results on Feb 09, 2026Nipro Corporation announced that they will report Q3, 2026 results on Feb 09, 2026
공시 • Sep 30Nipro Corporation to Report Q2, 2026 Results on Nov 10, 2025Nipro Corporation announced that they will report Q2, 2026 results on Nov 10, 2025
공시 • Jun 03Nipro Corporation to Report Q1, 2026 Results on Aug 08, 2025Nipro Corporation announced that they will report Q1, 2026 results on Aug 08, 2025
공시 • May 12+ 3 more updatesNipro Corporation, Annual General Meeting, Jun 26, 2025Nipro Corporation, Annual General Meeting, Jun 26, 2025.
공시 • Mar 04Nipro Corporation to Report Fiscal Year 2025 Results on May 12, 2025Nipro Corporation announced that they will report fiscal year 2025 results at 12:00 PM, Tokyo Standard Time on May 12, 2025
공시 • Dec 03Nipro Corporation to Report Q3, 2025 Results on Feb 07, 2025Nipro Corporation announced that they will report Q3, 2025 results on Feb 07, 2025
Reported Earnings • Nov 10Second quarter 2025 earnings released: JP¥15.31 loss per share (vs JP¥35.76 profit in 2Q 2024)Second quarter 2025 results: JP¥15.31 loss per share (down from JP¥35.76 profit in 2Q 2024). Revenue: JP¥159.6b (up 9.9% from 2Q 2024). Net loss: JP¥2.50b (down 143% from profit in 2Q 2024). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Sep 20Upcoming dividend of JP¥12.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 42% but the company is not cash flow positive. Trailing yield: 2.4%. Lower than top quartile of German dividend payers (4.8%). Higher than average of industry peers (1.9%).
공시 • Aug 29Nipro Corporation to Report Q2, 2025 Results on Nov 08, 2024Nipro Corporation announced that they will report Q2, 2025 results on Nov 08, 2024
Buy Or Sell Opportunity • Aug 06Now 22% overvaluedOver the last 90 days, the stock has fallen 2.7% to €7.15. The fair value is estimated to be €5.88, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.8% over the last 3 years. Earnings per share has declined by 25%. For the next 3 years, revenue is forecast to grow by 3.8% per annum. Earnings are also forecast to grow by 11% per annum over the same time period.
Declared Dividend • Jul 11Final dividend of JP¥12.00 announcedShareholders will receive a dividend of JP¥12.00. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 168%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (29% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 2.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 36% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Jun 02Nipro Corporation to Report Q1, 2025 Results on Aug 08, 2024Nipro Corporation announced that they will report Q1, 2025 results on Aug 08, 2024
Reported Earnings • May 13Full year 2024 earnings released: EPS: JP¥68.11 (vs JP¥28.05 in FY 2023)Full year 2024 results: EPS: JP¥68.11 (up from JP¥28.05 in FY 2023). Revenue: JP¥586.8b (up 7.6% from FY 2023). Net income: JP¥11.1b (up 143% from FY 2023). Profit margin: 1.9% (up from 0.8% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
공시 • May 12Nipro Corporation, Annual General Meeting, Jun 26, 2024Nipro Corporation, Annual General Meeting, Jun 26, 2024.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.1%. Lower than top quartile of German dividend payers (5.0%). Higher than average of industry peers (1.6%).
공시 • Mar 01Nipro Corporation to Report Fiscal Year 2024 Results on May 10, 2024Nipro Corporation announced that they will report fiscal year 2024 results on May 10, 2024
Reported Earnings • Feb 11Third quarter 2024 earnings released: EPS: JP¥16.54 (vs JP¥4.35 in 3Q 2023)Third quarter 2024 results: EPS: JP¥16.54 (up from JP¥4.35 in 3Q 2023). Revenue: JP¥153.3b (up 5.0% from 3Q 2023). Net income: JP¥2.70b (up 280% from 3Q 2023). Profit margin: 1.8% (up from 0.5% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
공시 • Nov 29Nipro Corporation to Report Q3, 2024 Results on Feb 08, 2024Nipro Corporation announced that they will report Q3, 2024 results on Feb 08, 2024
Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: JP¥35.76 (vs JP¥5.99 in 2Q 2023)Second quarter 2024 results: EPS: JP¥35.76 (up from JP¥5.99 in 2Q 2023). Revenue: JP¥145.3b (up 9.7% from 2Q 2023). Net income: JP¥5.83b (up 497% from 2Q 2023). Profit margin: 4.0% (up from 0.7% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥10.00 per share at 2.0% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 05 December 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.8%). In line with average of industry peers (2.0%).
공시 • Aug 27Nipro Corporation to Report Q2, 2024 Results on Nov 09, 2023Nipro Corporation announced that they will report Q2, 2024 results on Nov 09, 2023
New Risk • Aug 10New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 106% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.2% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (1.8% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 106% Paying a dividend despite having no free cash flows. Minor Risk Profit margins are more than 30% lower than last year (0.6% net profit margin).
Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: JP¥25.13 (vs JP¥32.34 in 1Q 2023)First quarter 2024 results: EPS: JP¥25.13 (down from JP¥32.34 in 1Q 2023). Revenue: JP¥140.6b (up 9.9% from 1Q 2023). Net income: JP¥4.10b (down 22% from 1Q 2023). Profit margin: 2.9% (down from 4.1% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Medical Equipment industry in Germany. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
공시 • May 28Nipro Corporation to Report Q1, 2024 Results on Aug 09, 2023Nipro Corporation announced that they will report Q1, 2024 results on Aug 09, 2023
Reported Earnings • May 14Full year 2023 earnings released: EPS: JP¥28.05 (vs JP¥82.50 in FY 2022)Full year 2023 results: EPS: JP¥28.05 (down from JP¥82.50 in FY 2022). Revenue: JP¥545.2b (up 10% from FY 2022). Net income: JP¥4.57b (down 66% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Medical Equipment industry in Germany.
공시 • May 13Nipro Corporation, Annual General Meeting, Jun 28, 2023Nipro Corporation, Annual General Meeting, Jun 28, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥8.50 per share at 2.2% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (1.7%).
Reported Earnings • Feb 09Third quarter 2023 earnings released: EPS: JP¥4.35 (vs JP¥22.90 in 3Q 2022)Third quarter 2023 results: EPS: JP¥4.35 (down from JP¥22.90 in 3Q 2022). Revenue: JP¥146.0b (up 15% from 3Q 2022). Net income: JP¥710.0m (down 81% from 3Q 2022). Profit margin: 0.5% (down from 2.9% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Germany.
공시 • Dec 01Nipro Corporation to Report Q3, 2023 Results on Feb 08, 2023Nipro Corporation announced that they will report Q3, 2023 results on Feb 08, 2023
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: JP¥5.99 (vs JP¥24.54 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.99 (down from JP¥24.54 in 2Q 2022). Revenue: JP¥132.4b (up 6.7% from 2Q 2022). Net income: JP¥977.0m (down 76% from 2Q 2022). Profit margin: 0.7% (down from 3.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Medical Equipment industry in Germany.
Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: JP¥5.99 (vs JP¥24.54 in 2Q 2022)Second quarter 2023 results: EPS: JP¥5.99 (down from JP¥24.54 in 2Q 2022). Revenue: JP¥132.4b (up 6.7% from 2Q 2022). Net income: JP¥977.0m (down 76% from 2Q 2022). Profit margin: 0.7% (down from 3.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Medical Equipment industry in Germany.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥13.50 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 06 December 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of German dividend payers (5.1%). Higher than average of industry peers (1.8%).
공시 • Aug 28Nipro Corporation to Report Q2, 2023 Results on Nov 09, 2022Nipro Corporation announced that they will report Q2, 2023 results on Nov 09, 2022
Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: JP¥32.34 (vs JP¥20.23 in 1Q 2022)First quarter 2023 results: EPS: JP¥32.34 (up from JP¥20.23 in 1Q 2022). Revenue: JP¥127.9b (up 8.4% from 1Q 2022). Net income: JP¥5.28b (up 60% from 1Q 2022). Profit margin: 4.1% (up from 2.8% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.3%, compared to a 7.4% growth forecast for the industry in Germany.
Reported Earnings • May 13Full year 2022 earnings released: EPS: JP¥82.50 (vs JP¥87.12 in FY 2021)Full year 2022 results: EPS: JP¥82.50 (down from JP¥87.12 in FY 2021). Revenue: JP¥494.8b (up 8.6% from FY 2021). Net income: JP¥13.5b (down 5.3% from FY 2021). Profit margin: 2.7% (down from 3.1% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 3.7%, compared to a 7.2% growth forecast for the industry in Germany.
공시 • May 13Nipro Corporation, Annual General Meeting, Jun 28, 2022Nipro Corporation, Annual General Meeting, Jun 28, 2022.
공시 • Apr 08Nipro Corporation to Report Fiscal Year 2022 Results on May 11, 2022Nipro Corporation announced that they will report fiscal year 2022 results on May 11, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.50 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. Payout ratio is a comfortable 35% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (3.6%). Higher than average of industry peers (1.1%).
Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥22.90 (down from JP¥30.07 in 3Q 2021). Revenue: JP¥127.2b (up 7.1% from 3Q 2021). Net income: JP¥3.74b (down 24% from 3Q 2021). Profit margin: 2.9% (down from 4.1% in 3Q 2021). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 4.8%, compared to a 12% growth forecast for the industry in Germany.
Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥24.54 (vs JP¥14.99 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥124.1b (up 9.5% from 2Q 2021). Net income: JP¥4.00b (up 64% from 2Q 2021). Profit margin: 3.2% (up from 2.2% in 2Q 2021).
Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.50 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 07 December 2021. Trailing yield: 2.5%. Lower than top quartile of German dividend payers (3.2%). Higher than average of industry peers (0.8%).
공시 • Sep 09Nipro Corporation's Ordinary Shares to Be Deleted from Other OTCNipro Corporation's Ordinary Shares will be deleted from other OTC effective from September 8, 2021 due to Inactive Security.
Reported Earnings • Aug 12First quarter 2022 earnings released: EPS JP¥20.23 (vs JP¥18.57 in 1Q 2021)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: JP¥118.0b (up 8.3% from 1Q 2021). Net income: JP¥3.30b (up 8.9% from 1Q 2021). Profit margin: 2.8% (in line with 1Q 2021).
Reported Earnings • May 14Full year 2021 earnings released: EPS JP¥87.12 (vs JP¥75.30 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥455.6b (up 2.9% from FY 2020). Net income: JP¥14.2b (up JP¥26.5b from FY 2020). Profit margin: 3.1% (up from net loss in FY 2020).
공시 • Mar 06Nipro Corporation to Report Fiscal Year 2021 Results on May 11, 2021Nipro Corporation announced that they will report fiscal year 2021 results on May 11, 2021
Is New 90 Day High Low • Feb 18New 90-day high: €10.90The company is up 18% from its price of €9.25 on 19 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Medical Equipment industry, which is up 28% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.22 per share.
Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS JP¥30.07 (vs JP¥30.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: JP¥118.8b (up 4.2% from 3Q 2020). Net income: JP¥4.90b (down 1.4% from 3Q 2020). Profit margin: 4.1% (down from 4.4% in 3Q 2020).
Analyst Estimate Surprise Post Earnings • Feb 10Revenue misses expectationsRevenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 7.6%, compared to a 14% growth forecast for the Medical Equipment industry in Germany.
공시 • Dec 03Nipro Corporation to Report Q3, 2021 Results on Feb 08, 2021Nipro Corporation announced that they will report Q3, 2021 results on Feb 08, 2021
Reported Earnings • Nov 17Second quarter 2021 earnings released: EPS JP¥14.99The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: JP¥113.3b (flat on 2Q 2020). Net income: JP¥2.44b (down 21% from 2Q 2020). Profit margin: 2.2% (down from 2.7% in 2Q 2020). The decrease in margin was driven by higher expenses.
Analyst Estimate Surprise Post Earnings • Nov 17Revenue misses expectationsRevenue missed analyst estimates by 5.6%. Over the next year, revenue is forecast to grow 7.2%, compared to a 13% growth forecast for the Medical Equipment industry in Germany.
Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS JP¥14.99The company reported a poor second quarter result with weaker earnings and profit margins, although revenues were flat. Second quarter 2021 results: Revenue: JP¥113.3b (flat on 2Q 2020). Net income: JP¥2.44b (down 21% from 2Q 2020). Profit margin: 2.2% (down from 2.7% in 2Q 2020). The decrease in margin was driven by higher expenses.
Is New 90 Day High Low • Nov 11New 90-day high: €11.50The company is up 21% from its price of €9.50 on 13 August 2020. The German market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Medical Equipment industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €5.26 per share.
Is New 90 Day High Low • Oct 27New 90-day low: €8.85The company is down 7.0% from its price of €9.50 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.45 per share.
공시 • Aug 23Nipro Corporation to Report Q2, 2021 Results on Nov 09, 2020Nipro Corporation announced that they will report Q2, 2021 results on Nov 09, 2020